Background: Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of
fetus and newborn (HDFN) aims to guide clinicians and the immunized women to focus on …

Hemolytic disease of the fetus and newborn and fetal and neonatal alloimmune
thrombocytopenia are caused by maternal antibodies against fetal alloantigens on red blood …

We developed and validated a next generation sequencing-(NGS) based NIPT assay using
quantitative counting template (QCT) technology to detect RhD, C, c, E, K (Kell), and Fya …

Introduction: ABO blood group incompatibility between a pregnant woman and her fetus as a
cause of morbidity or mortality of the fetus or newborn remains an important, albeit rare, risk …

RHD variants in D¯ Chinese pregnant women arose difficulties in management during
pregnancy. Therefore, this study aims to precisely manage D¯ pregnant women by …

Microhaplotypes (ie, microhaps or MHs) are emerging multi-allelic markers with at least two
single nucleotide polymorphisms (SNPs) within∼ 200 bp that have alleles of the same …

Rhesus D (RhD) negative pregnant women carrying an RhD positive fetus are at risk of
developing anti-D during or after pregnancy. Anti-d-immunoglobulin (RhIg), which is mainly …

Abstract Background and Objectives Non‐invasive assays for predicting foetal blood group
status in pregnancy serve as valuable clinical tools in the management of pregnancies at …

Purpose To evaluate the diagnostic accuracy of a commercially available test kit for
noninvasive prenatal determination of the fetal RhD status (NIPT-RhD) with a focus on early …

Background We sought to determine the cost‐effectiveness of noninvasive fetal RhD blood
group genotyping in nonalloimmunized and alloimmunized pregnancies in Canada. Study …